Loading insider details...
Latest Form 4 (Aug 20, 2026): Sale of 4,485 KROS shares, $46.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 20, 2026 | Keros Therapeutics, Inc. (KROS) | Sale | 4,485 | $46.2K |
| Mar 27, 2026 | Keros Therapeutics, Inc. (KROS) | Grant/Award | 80,000 | n/a |
| Feb 26, 2026 | Keros Therapeutics, Inc. (KROS) | Grant/Award | 80,000 | n/a |
| Feb 20, 2026 | Keros Therapeutics, Inc. (KROS) | Sale | 4,745 | $77.6K |